New study tracks lung disease in rheumatic patients
NCT ID NCT05819385
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how interstitial lung disease (ILD) affects people with rheumatic diseases like rheumatoid arthritis and lupus in Mexico. Researchers will track 312 patients over time to see how the lung disease progresses and what factors might make it worse. The goal is to better understand the condition and improve future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict and manage lung disease in people with rheumatic conditions, potentially improving care.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test any new therapy. Results may not apply outside the Mexican population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG DISEASES, INTERSTITIAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Colegio Mexicano de Reumatologia
RECRUITINGMexico City, 04318, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can scans replace breathing tests to monitor lung scarring?
- Skin patch could replace needle sticks during exercise tests
- Pigeon Lovers' lung disease: genes may hold the key
- Lung biopsy without a breathing tube? small study tests a gentler approach
- New injection aims to ease lung pressure in scarred lungs
- Ofev under the microscope: Real-World safety data for lung disease patients